Brentuximab vedotin - CAS 914088-09-8
Category: ADCs
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
COA:
Inquire
Tag:
ADCs Cytotoxin with Linkers
Description:
Brentuximab vedotin is an antibody-drug conjungate (ADC) used for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL). Brentuximab vedotin acts through targeting tumor cells with CD30 antigen expressed in.
Brife Description:
ADC, Hodgkin lymphoma (HL), anaplastic large cell lymphoma (ALCL)
Synonyms:
SGN-35; previously cAC10-vcMMAE; SGN 35; SGN35
MSDS:
Inquire
Application:
the treatment of Hodgkin lymphoma and ALCL
Current Developer:
Seattle Genetics; Takeda Pharmaceutical
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related ADCs Cytotoxin with Linkers Products


CAS 1342820-51-2 MC-Val-Ala-PBD

MC-Val-Ala-PBD
(CAS: 1342820-51-2)

MC-Val-Ala-PBD is a protective group conjugated PBD, PBD bind in the minor groove of DNA.

CAS 796073-68-2 DM4-SMe

DM4-SMe
(CAS: 796073-68-2)

DM4-SMe can be readily conjugate to the SH group of an antibody to form antibody-drug conjugate (ADC). .

CAS 452072-20-7 DM1-SPP

DM1-SPP
(CAS: 452072-20-7)

DM1 with a reactive linker SPP, which can react with antibody to make antibody drug conjugate, as a potent EGFR inhibitor and it overcomes resistant to EGFR.

CAS 1401963-17-4 Vc-MMAD

Vc-MMAD
(CAS: 1401963-17-4)

Vc-MMAD consists the ADCs linker(Val-Cit) and potent tubulin inhibitor (MMAD), Vc-MMAD is an antibody drug conjugate.

CAS 863971-24-8 Mc-MMAE

Mc-MMAE
(CAS: 863971-24-8)

Mc-MMAE is a protective group conjugated MMAE, MMAE inhibits tubulin polymerization so that it inhibits cell division.

Brentuximab vedotin
(CAS: 914088-09-8)

Brentuximab vedotin is an antibody-drug conjungate (ADC) used for the treatment of relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large ce...

Val-Cit-PAB-MMAE
(CAS: 644981-35-1)

Val-Cit-PAB-MMAE is a potent tubulin inhibitor (MMAE), Val-Cit-PAB-MMAE is an antibody drug conjugate.

CAS 1415329-13-3 Vat-Cit-PAB-MMAD

Vat-Cit-PAB-MMAD
(CAS: 1415329-13-3)

Vat-Cit-PAB-MMAD is a protective group conjugated MMAD, MMAD is a toxin payload in antibody drug conjugate.

Quick Inquiry

Verification code

Featured Items